289 related articles for article (PubMed ID: 11978774)
1. BY55/CD160 acts as a co-receptor in TCR signal transduction of a human circulating cytotoxic effector T lymphocyte subset lacking CD28 expression.
Nikolova M; Marie-Cardine A; Boumsell L; Bensussan A
Int Immunol; 2002 May; 14(5):445-51. PubMed ID: 11978774
[TBL] [Abstract][Full Text] [Related]
2. Identification of a novel CD160+ CD4+ T-lymphocyte subset in the skin: a possible role for CD160 in skin inflammation.
Abecassis S; Giustiniani J; Meyer N; Schiavon V; Ortonne N; Campillo JA; Bagot M; Bensussan A
J Invest Dermatol; 2007 May; 127(5):1161-6. PubMed ID: 17218942
[TBL] [Abstract][Full Text] [Related]
3. Membrane expression of NK receptors CD160 and CD158k contributes to delineate a unique CD4+ T-lymphocyte subset in normal and mycosis fungoides skin.
Sako N; Schiavon V; Bounfour T; Dessirier V; Ortonne N; Olive D; Ram-Wolff C; Michel L; Sicard H; Marie-Cardine A; Bagot M; Bensussan A; Schmitt C
Cytometry A; 2014 Oct; 85(10):869-82. PubMed ID: 25044837
[TBL] [Abstract][Full Text] [Related]
4. BY55/CD160 cannot be considered a cytotoxic marker in cytomegalovirus-specific human CD8(+) T cells.
Merino J; Ramírez N; Moreno C; Toledo E; Fernández M; Sánchez-Ibarrola A
Clin Exp Immunol; 2007 Jul; 149(1):87-96. PubMed ID: 17425655
[TBL] [Abstract][Full Text] [Related]
5. CD160Ig fusion protein targets a novel costimulatory pathway and prolongs allograft survival.
D'Addio F; Ueno T; Clarkson M; Zhu B; Vergani A; Freeman GJ; Sayegh MH; Ansari MJ; Fiorina P; Habicht A
PLoS One; 2013; 8(4):e60391. PubMed ID: 23593209
[TBL] [Abstract][Full Text] [Related]
6. T cell receptor-triggered activation of intraepithelial lymphocytes in vitro.
Gramzinski RA; Adams E; Gross JA; Goodman TG; Allison JP; Lefrançois L
Int Immunol; 1993 Feb; 5(2):145-53. PubMed ID: 8383994
[TBL] [Abstract][Full Text] [Related]
7. Cloning of BY55, a novel Ig superfamily member expressed on NK cells, CTL, and intestinal intraepithelial lymphocytes.
Anumanthan A; Bensussan A; Boumsell L; Christ AD; Blumberg RS; Voss SD; Patel AT; Robertson MJ; Nadler LM; Freeman GJ
J Immunol; 1998 Sep; 161(6):2780-90. PubMed ID: 9743336
[TBL] [Abstract][Full Text] [Related]
8. CD28 interaction with B7 costimulates primary allogeneic proliferative responses and cytotoxicity mediated by small, resting T lymphocytes.
Azuma M; Cayabyab M; Buck D; Phillips JH; Lanier LL
J Exp Med; 1992 Feb; 175(2):353-60. PubMed ID: 1370679
[TBL] [Abstract][Full Text] [Related]
9. Cutting edge: MHC class I triggering by a novel cell surface ligand costimulates proliferation of activated human T cells.
Agrawal S; Marquet J; Freeman GJ; Tawab A; Bouteiller PL; Roth P; Bolton W; Ogg G; Boumsell L; Bensussan A
J Immunol; 1999 Feb; 162(3):1223-6. PubMed ID: 9973372
[TBL] [Abstract][Full Text] [Related]
10. CD5 acts as a tyrosine kinase substrate within a receptor complex comprising T-cell receptor zeta chain/CD3 and protein-tyrosine kinases p56lck and p59fyn.
Burgess KE; Yamamoto M; Prasad KV; Rudd CE
Proc Natl Acad Sci U S A; 1992 Oct; 89(19):9311-5. PubMed ID: 1384049
[TBL] [Abstract][Full Text] [Related]
11. A soluble form of the MHC class I-specific CD160 receptor is released from human activated NK lymphocytes and inhibits cell-mediated cytotoxicity.
Giustiniani J; Marie-Cardine A; Bensussan A
J Immunol; 2007 Feb; 178(3):1293-300. PubMed ID: 17237375
[TBL] [Abstract][Full Text] [Related]
12. Cutting edge: engagement of CD160 by its HLA-C physiological ligand triggers a unique cytokine profile secretion in the cytotoxic peripheral blood NK cell subset.
Barakonyi A; Rabot M; Marie-Cardine A; Aguerre-Girr M; Polgar B; Schiavon V; Bensussan A; Le Bouteiller P
J Immunol; 2004 Nov; 173(9):5349-54. PubMed ID: 15494480
[TBL] [Abstract][Full Text] [Related]
13. The co-expression of 2B4 (CD244) and CD160 delineates a subpopulation of human CD8+ T cells with a potent CD160-mediated cytolytic effector function.
Rey J; Giustiniani J; Mallet F; Schiavon V; Boumsell L; Bensussan A; Olive D; Costello RT
Eur J Immunol; 2006 Sep; 36(9):2359-66. PubMed ID: 16917959
[TBL] [Abstract][Full Text] [Related]
14. 4-1BB is superior to CD28 costimulation for generating CD8+ cytotoxic lymphocytes for adoptive immunotherapy.
Zhang H; Snyder KM; Suhoski MM; Maus MV; Kapoor V; June CH; Mackall CL
J Immunol; 2007 Oct; 179(7):4910-8. PubMed ID: 17878391
[TBL] [Abstract][Full Text] [Related]
15. The CD160+ CD8high cytotoxic T cell subset correlates with response to HAART in HIV-1+ patients.
Nikolova MH; Muhtarova MN; Taskov HB; Kostov K; Vezenkov L; Mihova A; Boumsell L; Bensussan A
Cell Immunol; 2005 Oct; 237(2):96-105. PubMed ID: 16337931
[TBL] [Abstract][Full Text] [Related]
16. Expanded antigen-experienced CD160
Bozorgmehr N; Okoye I; Oyegbami O; Xu L; Fontaine A; Cox-Kennett N; Larratt LM; Hnatiuk M; Fagarasanu A; Brandwein J; Peters AC; Elahi S
J Immunother Cancer; 2021 Apr; 9(4):. PubMed ID: 33931471
[TBL] [Abstract][Full Text] [Related]
17. Cytotoxic T lymphocyte antigen 4 and CD28 modulate cell surface raft expression in their regulation of T cell function.
Martin M; Schneider H; Azouz A; Rudd CE
J Exp Med; 2001 Dec; 194(11):1675-81. PubMed ID: 11733581
[TBL] [Abstract][Full Text] [Related]
18. Co-receptor-independent signal transduction in a mismatched CD8+ major histocompatibility complex class II-specific allogeneic cytotoxic T lymphocyte.
Eshima K; Tachibana M; Suzuki H; Yamazaki S; Shinohara N
Eur J Immunol; 1997 Jan; 27(1):55-61. PubMed ID: 9021998
[TBL] [Abstract][Full Text] [Related]
19. CD69-mediated pathway of lymphocyte activation: anti-CD69 monoclonal antibodies trigger the cytolytic activity of different lymphoid effector cells with the exception of cytolytic T lymphocytes expressing T cell receptor alpha/beta.
Moretta A; Poggi A; Pende D; Tripodi G; Orengo AM; Pella N; Augugliaro R; Bottino C; Ciccone E; Moretta L
J Exp Med; 1991 Dec; 174(6):1393-8. PubMed ID: 1720808
[TBL] [Abstract][Full Text] [Related]
20. A novel 80-kD cell surface structure identifies human circulating lymphocytes with natural killer activity.
Maïza H; Leca G; Mansur IG; Schiavon V; Boumsell L; Bensussan A
J Exp Med; 1993 Sep; 178(3):1121-6. PubMed ID: 7688788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
